Loading organizations...
Biopharmaceutical company developing advanced cell therapies for blood canc
Gamida Cell has raised $124.4M across 6 funding rounds.
Gamida Cell has raised $124.4M in total across 6 funding rounds.
Gamida Cell has raised $124.4M in total across 6 funding rounds.
Gamida Cell's investors include Highbridge Capital Management.
Gamida Cell has raised $124.4M across 6 funding rounds. Most recently, it raised $30.0M Other Equity in June 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 18, 2024 | $30.0M Other Equity | Highbridge Capital Management | |
| Jun 19, 2017 | $40.0M Other Equity | ||
| May 23, 2016 | $4.4M Grant | ||
| Oct 12, 2015 | $5.0M Other Equity | ||
| Aug 22, 2014 | $35.0M Other Equity | ||
| May 15, 2012 | $10.0M Series E |